Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 11 - 20 of 327

Selected Filters:
17 April 2026

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.

Normative Guidance/Policies, Service Delivery

Document
31 March 2026

LEN Learning Clinic: Innovations in Service Delivery & Facility-Level Implementation

This interactive learning clinic brings together governments, implementing partners, and technical assistance teams to share and discuss early insights from LEN introduction — with a focus on practical service delivery innovations from the field. This will be interactive— come ready to engage. Featured Speakers: Dr Chimika Phiri, Ministry of Health, Zambia- Early insights from Zambia’s…

Service Delivery

Event
6 March 2026

Bridging HIV Prevention and Sexual Reproductive Health Services in the Context of Multi-method PrEP: A qualitative study exploring Provider Perceptions in South Africa

This article from Frontiers in Reproductive Health describes a study examining health care providers’ perspectives on the integration of PrEP and sexual and reproductive health services in South Africa.

Service Delivery

External Link
26 February 2026

Early Experiences with Usage of Long-acting Injectable Cabotegravir among Adults in Rural Ugandan and Kenyan Communities: Qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

This article from Journal of the International AIDS Society describes the results of a qualitative study exploring experiences with injectable cabotegravir (CAB for PrEP) among adults participating in the SEARCH Dynamic Choice HIV Prevention (DCP) trial in rural Kenya and Uganda, which evaluated HIV prevention uptake through a structured, person-centred DCP model.

Community/Advocacy, Research, Service Delivery

External Link
9 February 2026

The Injectors of Tomorrow are Here Today

An important part of expanding PrEP access includes increasing the number of individuals who can deliver PrEP, particularly injectable PrEP, and the locations where PrEP can be administered and obtained. Join The Choice Agenda to hear from community health workers and pharmacists who are taking actions outside the box such as learning to inject, and…

Service Delivery

Event
9 February 2026

Dapivirine Ring: Giving Women Hope and Choice in HIV Prevention

Recording / Transcript / Slides / Resources The monthly Dapivirine Vaginal Ring (DVR) is a critical option in the HIV prevention toolkit, being entirely woman controlled, discrete, and very safe and simple to implement. This webinar will highlight ongoing Market Access activities to ensure women have access to the monthly DVR; key learnings from community…

Community/Advocacy, Research, Service Delivery

Event
9 February 2026

Lenacapavir Training Videos

These videos, developed by South Africa’s National Department of Health, can be used to train providers offering injectable lenacapavir (LEN) for PrEP, and include modules on screening, initiation, counselling, follow-up, side effects, special considerations, and reporting.

Service Delivery

External Link
9 February 2026

Lenacapavir Implementation Planning Tool

This tool, developed by South Africa’s National Department of Health, can be used to develop action plans for facilities introducing injectable lenacapavir (LEN).

Monitoring & Evaluation, Service Delivery, Supply Chain Management

Spreadsheet
5 February 2026

GBGMC Country Profiles

These country profiles provide concise, actionable snapshots of the HIV prevention and treatment landscape for key populations across multiple countries, including: Brazil, Eswatini, France, Kenya, Malawi, Mozambique, Nigeria, the Philippines, South Africa, Uganda, Ukraine, the United States, Vietnam, Zambia, and Zimbabwe. Country profiles highlight: History of PrEP introduction Updates on PrEP Products Key population epidemiology…

Community/Advocacy, Demand Creation/Marketing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

External Link
6 January 2026

Country Planning for Product Introduction Matrix

AVAC’s Country Planning for Product Introduction Matrix tracks key indicators for the introduction of new PrEP products, including lenacapavir (LEN), cabotegravir (CAB), and the Dapivirine Vaginal Ring (DVR), by country, including regulatory status, late stage clinical trials and implementation research, procurement plans, and recent oral PrEP provision.

Research, Service Delivery

External Link